These data suggest that the levels of ATR, CHK1, especially WEE1, modulate cisplatin mediated cell death and survival, which is also reflected by our analysis of clinic data on ovarian cancer patients and breast cancer patients undergone chemotherapy, which contains cisplatin. This evidence concerns the gene CHEK1 and ovarian carcinoma.